Why did researchers give MDMA to octopuses?
To test whether MDMA alters social behavior in a species that is normally asocial; the drug made octopuses markedly more social, indicating conserved molecular mechanisms across distant taxa.
Video Summary
MDMA made normally asocial octopuses unusually social, suggesting conserved molecular targets across distant species.
Psychedelics appear to reopen developmental 'critical periods' and restore plasticity, enabling relearning and therapy.
Different psychedelics act on different receptors but converge on metaplasticity and extracellular-matrix remodeling.
Therapeutic uses include PTSD treatment, addiction interventions (ibogaine research), and potential motor rehab support.
Set, setting, and clinical support are essential; psychedelics are not a cure for neurodegeneration and carry risks and legal limits.
To test whether MDMA alters social behavior in a species that is normally asocial; the drug made octopuses markedly more social, indicating conserved molecular mechanisms across distant taxa.
A critical period is a developmental window of heightened plasticity when the brain readily learns specific skills; reopening these periods with psychedelics may allow relearning or therapeutic rewiring in adulthood.
No—different compounds act on different targets (e.g., MDMA on serotonin transporters, ketamine on NMDA, psilocybin on 5‑HT2A) but they may converge on metaplasticity and extracellular-matrix changes that restore plasticity.
Current evidence suggests psychedelics restore plasticity but do not regrow lost neurons, so they are unlikely to stop neurodegeneration though they might aid rehab by enabling alternative learning pathways.
The noetic property refers to the strong sense of insight or certainty people report under psychedelics—experientially meaningful but not necessarily objectively true, requiring careful therapeutic framing.
“I gave them MDMA and we asked what happens to their social behavior.”
“If Earth rotated once in 90 minutes rather than in 24 hours, the centrifugal force of that rotation would render everyone on the equator weightless.”
“What happens if we give it a nudge? What if I told you we can take back our brains to a time when it was eager to learn the lessons that would last a lifetime?”
“You are a professor at UC Berkeley in the department of psychology, but you're also attached to the departments of psychedelics and neuroscience.”
“LSD was formulated as a respiratory and circulatory treatment in 1938.”
“We think that psychedelics reopen critical periods.”
“If you give them MDMA, then their behavior completely changes.”
The discussion revolves around a fascinating experiment where octopuses, known for their asocial behavior, were administered MDMA to observe changes in their social interactions. Normally, octopuses might kill each other when placed in the same tank, but under the influence of MDMA, they displayed markedly different behavior, indicating increased sociability.
The researcher noted that octopuses, without the drug, are typically solitary and aggressive, but with MDMA, they expressed affection and camaraderie, culminating in humorous and affectionate exchanges among them.
“MDMA binds to the same transporter protein that a selective serotonin reuptake inhibitor like Prozac binds to.”
An explanation of how MDMA interacts with the brain reveals that it binds to serotonin transporters, but unlike SSRIs such as Prozac that inhibit serotonin reuptake, MDMA reverses the process, leading to a release of serotonin into the synapse. This mechanism is responsible for the feelings of euphoria often reported by users.
The discussion highlights the profound physiological responses MDMA elicits and explores how its effects may vary from person to person, citing the complexities behind the ‘hangover’ some experience after the drug wears off.
“I think that there is a common mechanism across all of the psychedelics.”
The video clarifies that while different psychedelics operate through distinct receptor mechanisms—like ketamine primarily influencing NMDA receptors and substances like psilocybin affecting serotonin 2A receptors—all psychedelics seem to converge on a common outcome. They are believed to enhance a process known as "metaplasticity," enabling improved brain plasticity.
It was explained that despite the varied initial receptor interactions, the underlying impact of psychedelics involves remodeling of the extracellular matrix in the brain, unifying their effects at a biochemical level.
“Plasticity is something that happens all the time.”
A significant point made in the video relates to the concept of brain plasticity, which refers to the brain's ability to adapt and reorganize itself. Engaging in strong emotional experiences, such as conversations or personal milestones, can create lasting memories through this plasticity.
It’s emphasized that while psychedelics may not create massive plasticity directly during the experience, they appear to restore the brain's ability to induce plasticity, thereby reinstating a youthful capacity for adaptation and learning, crucial for therapeutic outcomes.
"When I say plasticity, I am talking about synaptic plasticity, which is a change in the synaptic weights that are encoded."
The conversation begins with a discussion on the concept of brain plasticity, specifically focusing on synaptic plasticity. This refers to the ability of synaptic connections between neurons to strengthen or weaken over time, based on activity and experiences.
It’s explained that when neurons communicate, the strength of their connections can change, which is crucial for how memories are formed and represented in the brain.
A central theme discussed is "neurons that wire together fire together," meaning that synchronous activity between neurons leads to lasting connections, while those that do not synchronize may lose their connections.
"The way that the brain encodes memories is by population coding."
The complex nature of how memories are encoded in the brain is highlighted. Instead of a singular neuron representing a memory—often referred to as the "grandmother cell" theory—memory encoding is more accurately described as population coding.
This means that memories are not localized to one neuron but are represented by patterns of activity across many neurons. An analogy is drawn between memory encoding and QR codes, where the arrangement of dots (or synapses) encodes information rather than the intensity of the entire block.
"Memories can be unreliable, as they are constantly modified."
The reliability of memories is questioned, especially when they are viewed as being dynamic and subject to change. Highly robust memories are those reinforced by multiple networks of neurons triggered by various cues, such as emotions or significant experiences.
Everyday occurrences, however, may only get encoded in the least redundant way, making them more susceptible to forgetting over time.
"Neuroscientists have been dreaming of a way to reopen critical periods since 1935."
The idea of critical periods in brain development, first identified through studies on imprinting in geese, is a central focus. Critical periods refer to windows of time during development when the brain is particularly receptive to certain types of learning and experiences.
Recent findings from neuroscience research suggest that psychedelics may hold the potential to reopen these critical periods, creating new pathways for learning and memory.
The discussion emphasizes that while there are apprehensions about reopening critical periods, as it may bring back suppressed memories or emotions, the pursuit of this research remains significant for understanding and treating brain disorders.
"If we learned something that was adaptive at the time but is no longer adaptive, the ways of responding to past trauma could hinder our current life."
Traumatic experiences from childhood can lead to protective but maladaptive behaviors, such as hyper-vigilance and distrust.
As individuals mature and threats diminish, these learned behaviors may become inappropriate for their current situation, necessitating a re-evaluation of past memories and behaviors.
"Psychedelics help in reopening critical periods of learning to reconfigure memories and behavioral patterns relevant to current circumstances."
Psychedelics, like MDMA, can assist in therapeutic contexts, especially for conditions like PTSD. They allow individuals to revisit traumas and change their perspectives.
However, these substances must be used in conjunction with therapeutic support rather than as standalone treatments for optimal effectiveness.
"The effects of psychedelics are heavily influenced by the set—your mindset—and the setting, your environment."
The experiences during psychedelic use can vary drastically depending on the individual's mindset and environmental context. Positive or negative experiences can shape the outcomes significantly.
For instance, taking MDMA at a rave may not yield the same therapeutic benefits as when taken in a more supportive setting designed for therapy.
"Psychedelics are associated with a feeling of deep knowledge and understanding of reality, termed the knowetic property."
This property suggests that when individuals use psychedelics, they often believe they gain insights and understanding beyond their previous limited viewpoints.
While this can have therapeutic benefits, it can also lead to overconfidence and a false sense of knowledge if not approached carefully.
"From the moon, international politics looks petty. You want to drag a politician a quarter million miles out to show them Earth."
The experience of Apollo 14 astronaut Edgar Mitchell reshaped his understanding of humanity's place in the universe and drove him to create the Noetic Institute.
His insights are a reminder of how profound experiences—like seeing Earth from space—can alter one's perception of reality and motivate action towards global consciousness.
"The idea that you can't teach an old dog new tricks might be overturned with the possibility of using psychedelics."
Psychedelics may also be used to enhance learning abilities in adults, extending beyond just therapeutic effects to learning new skills.
Current research aims to explore the effectiveness of psychedelics, like psilocybin, in reopening critical periods for motor skills learning, especially after events like strokes.
"Can we get improvements in motor function and rehabilitation by using psilocybin in conjunction with physical and occupational therapy?"
Researchers are considering the use of psilocybin to enhance motor function and rehabilitation. This innovative approach pairs psilocybin with traditional therapies to improve patient outcomes.
While the therapeutic context is promising for motor learning, the potential limitations of using psychedelics in patients with neurodegenerative conditions, such as Alzheimer's or Parkinson's, have been acknowledged.
"Unfortunately, this mechanism doesn't really suggest a way that it would be useful for Alzheimer's or Parkinson's."
Current findings indicate that psychedelics do not promote the regrowth of neurons, which is crucial for treating neurodegenerative diseases.
Although psychedelics could potentially aid in motor therapy by facilitating alternative pathways for functions like swallowing, the underlying degenerative processes remain unchanged and would continue to progress.
"Could you use these psychedelics to reopen a period where the chemical attraction between two people was greatest?"
There is potential to utilize psychedelics to rekindle emotional connections in relationships by fostering vulnerability and openness.
Historical use of MDMA in couples therapy highlights how psychedelics can facilitate honest and vulnerable communication, allowing couples to navigate conflicts more easily.
"Psychedelics can foster this type of behavior—this altered state called love."
The discussion shifts to different types of love and the role of oxytocin in establishing emotional bonds.
Research has identified oxytocin neurons that encode different aspects of love, including deeply romantic and platonic forms. This distinction is essential for understanding how love evolves in human relationships.
"Ibeane is a psychedelic that can induce a dreamlike state, leading to life reviews that are important for psychological healing."
Ibogaine, a psychedelic derived from the iboga plant, has shown promise in treating PTSD, addiction, and depression, particularly among veterans.
This compound is illegal in the U.S. but has a more ambiguous legal status in other countries, making it accessible for therapeutic use outside of the United States.
"Americans for Ibogaine has launched a public awareness campaign to promote the research of ibogaine for opioid crisis intervention."
Awareness and legislative campaigns aim to explore ibogaine's therapeutic applications, addressing the opioid crisis through dedicated research funding.
Recent government acknowledgments highlight the urgency of investigating ibogaine as a treatment option, reflecting an acknowledgment of its potential benefits despite its risks, such as cardiotoxicity in patients with pre-existing heart conditions.
"The National Institute of Drug Abuse has given a group at Harvard an 11 million dollar grant to work on a phase one safety study for ibeane."
The FDA and DEA are not only interested in supporting research on ibeane but have also funded a Harvard group to study its safety for treating opioid use disorder.
This research aims to determine if ibeane can be medically used to address opioid addiction, which could become pivotal in treating this prevalent issue.
"Many of these rules are 50 years out of date, and there must be a sensible way to keep laboratories active and vibrant in exploring these connections."
There's a pressing need to reevaluate outdated drug scheduling regulations that hinder research and treatment efficacy.
Organizations like MAPS have been working for decades to present clinical data showing that certain drugs, previously classified as Schedule I, possess therapeutic benefits.
"Marijuana was once classified as a Schedule I substance because of misconceptions about its use in the black community."
The historical context of marijuana's classification reveals biases, particularly against African American communities, leading to disproportionate legal consequences.
This reflects a broader pattern where substances predominantly used in marginalized communities face harsher scrutiny compared to those used in different demographics.
"No one wants to be addicted to drugs, and treating addiction as a criminal issue is counterproductive."
There is a national stigma suggesting that individuals with substance use disorders deserve criminal punishment instead of medical assistance, which is a misguided approach.
Understanding that addiction is not a choice but a hijacked brain response can transform how society addresses and treats addiction.
"The study of psychedelics has convinced me even more that we live in a physicalist reality."
Research into psychedelics suggests they mimic existing brain molecules, altering consciousness and perceptions in a way that emphasizes the physical basis of reality.
The effect of these substances illustrates that consciousness results from basic chemical interactions, reinforcing a physicalist perspective.
"The brain needs a mechanism for reopening critical periods when the environment changes."
Interventions, both chemical (like psychedelics) and experiential (like sensory deprivation), can help reopen critical learning periods in the brain, allowing adaptation to new conditions.
These mechanisms are evolutionary adaptations that help organisms reset their learning processes when faced with significant environmental changes, such as moving into a new culture.
"Why not do this on dogs and demonstrate that you can teach an old dog new tricks?"
The discussion highlights the peculiar choice of octopuses as experimental subjects when studying complex behaviors, especially in comparison to more relatable animals like dogs.
The assertion is made that testing this concept on dogs would provide more applicable insights since they are mammals with similar neurological structures, unlike octopuses, which are invertebrates with radically different brain anatomy.
"It allows us to understand how to build complex behaviors from synapses, molecules, circuits."
The reasoning behind examining octopuses stems from a long-standing debate in neuroscience, where understanding behaviors requires observing both closely related and vastly different species.
By analyzing octopuses, researchers avoid being "distracted by accidents of evolutionary history," as these creatures lack many common brain structures found in mammals, like the cerebral cortex or amygdala, yet can produce complex behaviors.
"The true mechanism is really at the level of molecules."
It is argued that the insights gained from octopuses suggest that behavioral mechanisms can exist independently of traditional brain structures typically studied in mammals, pointing to a more molecular basis for behavior.
This reframing encourages researchers to consider various anatomical toolkits across species rather than relying solely on neuroanatomical comparisons based on evolutionary lineage.
"Maybe they don't need critical periods in the same way that we do."
The conversation shifts to the unique traits of octopuses, including their ability to regrow limbs, which may alter their developmental timelines and behavioral flexibility compared to mammals.
Researchers express a desire to explore how the genetic and biological traits of octopuses could inform potential medical breakthroughs in humans, allowing them to "co-opt their superpowers" for therapeutic purposes.
"Exercise some caution about that kind of anthropomorphizing."
The tendency to anthropomorphize octopuses is recognized, as their complex behaviors can often lead people to attribute human-like intelligence and emotional responses to them.
Comparisons to other animals, like dogs and bears, emphasize that while octopuses display remarkable adaptations, their evolutionary trajectory and sensory perceptions differ significantly from mammals.